Download Free Sample Report

Automated Peptide Synthesizer is an instrument used for peptide synthesis according to the principle of solid phase peptide synthesis.
This report contains market size and forecasts of Automated Peptide Synthesizer in global, including the following market information:

• Global Automated Peptide Synthesizer Market Revenue, 2018-2023, 2023-2030, ($ millions)
• Global Automated Peptide Synthesizer Market Sales, 2018-2023, 2023-2030, (K Units)
• Global top five Automated Peptide Synthesizer companies in 2022 (%)

The global Automated Peptide Synthesizer market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Single Channel Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Automated Peptide Synthesizer include Gyros Protein Technologies AB, Bchi AG, Biotage, CEM, CSBio, AAPPTec, Activotec, MultiSynTech and NJ Biopharmaceuticals LLC, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Automated Peptide Synthesizer manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Automated Peptide Synthesizer Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Automated Peptide Synthesizer Market Segment Percentages, by Type, 2022 (%)

• Single Channel
• Multi-channel

Global Automated Peptide Synthesizer Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Automated Peptide Synthesizer Market Segment Percentages, by Application, 2022 (%)

• School Laboratory
• Biopharmaceutical Company
• Synthesis Services Company

Global Automated Peptide Synthesizer Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Automated Peptide Synthesizer Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Automated Peptide Synthesizer revenues in global market, 2018-2023 (Estimated), ($ millions)
• Key companies Automated Peptide Synthesizer revenues share in global market, 2022 (%)
• Key companies Automated Peptide Synthesizer sales in global market, 2018-2023 (Estimated), (K Units)
• Key companies Automated Peptide Synthesizer sales share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Gyros Protein Technologies AB
• Bchi AG
• Biotage
• CEM
• CSBio
• AAPPTec
• Activotec
• MultiSynTech
• NJ Biopharmaceuticals LLC
• Peptide Machines, Inc.
• Protein Technologies, Inc.
• Intavis AG
• HAINAN JIANBANG PHARMACEUTICAL